Device and drug manufacturer
H.R. 3026 - Safeguarding America's Pharmaceuticals Act of 2011;  P.L. 111-14 - Patient Protection and Affordable Health Care Act provisions relating to biosimilar products; S. 2295 - Patient Safety and Generic Labeling Improvement Act; Senate Draft Proposal to Improve Drug Distribution Security.
HCR - Health Issues
135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BROWN RUDNICK LLP
601 13th Street, NW, 6th Floor, Washington, DC, 20005, US
HENRY W MENN (Min SD & Counsel, Cmte on Vet Affairs (04)) LISA LAYMAN (SPA, Sen Stabenow(05-07))
Min SD & Counsel, Cmte on Vet Affairs (04) SPA, Sen Stabenow(05-07)